Salt Lake City, March 9 - BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center, today announced the six Utah life sciences startup companies that have qualified to pitch to investors and guests attending the 2023 Entrepreneur & Investor Life Sciences Summit (Summit). The conference will be held on March 16 at the University of Utah’s Cleone Peterson Eccles Alumni House in Salt Lake City and is proudly sponsored by Wilson Sonsini.
The six companies listed below were selected from over 30 companies that applied to present: These companies were chosen based on a number of criteria, including uniqueness of the product, potential of the product for commercialization, and quality of management. For information on the companies and a complete agenda visit www.eilifesciencessummit.org.
- 3Helix is a revenue generating seed stage company with a first-of-its kind platform technology called Collagen Hybridizing Peptides (CHPs) for conditions like Atopic Dermatitis, Osteoarthritis, and others.
- BirchOS is the first Pharma Enterprise Resource Planning (ERP) built around sterilization compliance. It was built for pharma by pharma and offers complete pharmaceutical and warehouse management software. BirchOS confirms sterilization compliance, inventory compliance, licensing, payments, inventory management, CEO dashboards and more.
- Focused Therapeutics is a start-up medical device company developing Focused Electric Field (FEF) technology for use in cardiac ablation procedures for the treatment of arrhythmias.
- NanoSpot.ai is a medical diagnostic platform leveraging a blood-spot-based approach and an artificial intelligence-driven mobile application to provide low-cost, accurate, and quantitative diagnostic results to the point of care.
- nView Medical, is a commercial stage surgical imaging company with the thesis that dependable 3D imaging information is the key to successful surgeries.
- Phoenix PharmaLabs has a portfolio of drugs under development with unique opioid receptor characteristics that do not produce the euphoric “high” that leads to abuse and addiction.
“We had a tremendous response to our call for applications from our life sciences community,” said Kelvyn Cullimore, president and CEO, of BioUtah. “The six companies that are advancing to the Pitch Competition, and every company that threw their hat in the ring, deserve recognition. They all reflect Utah’s proud tradition of discovery and entrepreneurship.”
Many of the companies not pitching in the competition are presenting in the virtual Pitch Hall, which is available through the Whova app being used for the Summit. The novel products being developed by these companies can be viewed using the app.
“The Pitch Competition will underscore the tremendous amount of healthcare innovation happening in Utah,” said Keith Marmer, chief innovation and economic engagement officer at the University of Utah. ”Our aim is to showcase our promising life sciences startups to local and national investors and ultimately help bring new treatments and cures to patients.”
The six companies will pitch live to Summit attendees, angel investors, and representatives from venture capital funds. Finalists will be selected by a panel of industry leaders and investor experts. Winners will be announced at an awards ceremony to close the Summit.
About the PIVOT Center
